Therapeutic angiogenesis: a step forward in intermittent claudication

被引：15

作者：

Donnelly, R ^{[1
]}

Yeung, JMC

机构：

[1] So Derbyshire Acute Hosp NHS Trust, Derby DE1 2QY, England

[2] Univ Nottingham, Sch Med & Surg Sci, Nottingham NG7 2RD, England

来源：

LANCET | 2002年 / 359卷 / 9323期

关键词：

D O I：

10.1016/S0140-6736(02)08946-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2048 / 2050

页数：3

共 11 条

[1] Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].

Baumgartner, I ;

Pieczek, A ;

Manor, O ;

Blair, R ;

Kearney, M ;

Walsh, K ;

Isner, JM .

CIRCULATION, 1998, 97 (12) :1114-1123

[2] A new pharmacological treatment for intermittent claudication:: Results of a randomized, multicenter trial [J].

Beebe, HG ;

Dawson, DL ;

Cutler, BS ;

Herd, JA ;

Strandness, DE ;

Bortey, EB ;

Forbes, WP .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (17) :2041-2050

[3] Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion - Evidence for a dose-dependent effect [J].

Hendel, RC ;

Henry, TD ;

Rocha-Singh, K ;

Isner, JM ;

Kereiakes, DJ ;

Giordano, FJ ;

Simons, M ;

Bonow, RO .

CIRCULATION, 2000, 101 (02) :118-121

[4] Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study [J].

Laham, RJ ;

Chronos, NA ;

Pike, M ;

Leimbach, ME ;

Udelson, JE ;

Pearlman, JD ;

Pettigrew, RI ;

Whitehouse, MJ ;

Yoshizawa, C ;

Simons, M .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) :2132-2139

[5] Basic fibroblast growth factor in patients with intermittent claudication: Results of a phase I trial [J].

Lazarous, DF ;

Unger, EF ;

Epstein, SE ;

Stine, A ;

Arevalo, JL ;

Chew, EY ;

Quyyumi, AA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (04) :1239-1244

[6] Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution [J].

Lazarous, DF ;

Shou, M ;

Stiber, JA ;

Dadhania, DM ;

Thirumurti, V ;

Hodge, E ;

Unger, EF .

CARDIOVASCULAR RESEARCH, 1997, 36 (01) :78-85

[7] KINETICS OF BASIC FIBROBLAST GROWTH-FACTOR BINDING TO ITS RECEPTOR AND HEPARAN-SULFATE PROTEOGLYCAN - A MECHANISM FOR COOPERATIVITY [J].

NUGENT, MA ;

EDELMAN, ER .

BIOCHEMISTRY, 1992, 31 (37) :8876-8883

[8] BASIC FIBROBLAST GROWTH-FACTOR IS CARDIOPROTECTIVE IN ISCHEMIA-REPERFUSION INJURY [J].

PADUA, RR ;

SETHI, R ;

DHALLA, NS ;

KARDAMI, E .

MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 143 (02) :129-135

[9] Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs [J].

Rajanayagam, MAS ;

Shou, M ;

Thirumurti, V ;

Lazarous, DF ;

Quyyumi, AA ;

Goncalves, L ;

Stiber, J ;

Epstein, SE ;

Unger, EF .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :519-526

[10] Augmentation of postnatal neovascularization with autologous bone marrow transplantation [J].

Shintani, S ;

Murohara, T ;

Ikeda, H ;

Ueno, T ;

Sasaki, K ;

Duan, JL ;

Imaizumi, T .

CIRCULATION, 2001, 103 (06) :897-903

← 1 2 →